Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Naltrexone Treatment for Prolonged Grief Disorder: A Proof of Concept Study

NCT06140420 is registered in ClinicalTrials.gov with Texas Tech University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06140420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Naltrexone Treatment for Prolonged Grief Disorder: A Proof of Concept Study
Lead sponsor
Texas Tech University
Phase
Phase 4
Overall status
Terminated
Start date
August 1, 2023
Completion date
February 1, 2025
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

naltrexone hcl 50 mg oral tablet, placebo